Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.28 USD | 0.00% | +8.93% | -4.23% |
05-10 | Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating | MT |
05-09 | Earnings Flash (TELA) TELA BIO Posts Q1 Revenue $16.6M, vs. Street Est of $16.3M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.23% | 155M | |
-6.50% | 180B | |
+3.11% | 112B | |
-3.41% | 68.53B | |
+5.26% | 51.97B | |
+5.49% | 44.08B | |
+5.62% | 42.23B | |
+23.76% | 32.43B | |
+16.72% | 26.39B | |
-3.39% | 24.97B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- TELA Bio Says FDA Grants 510(k) Clearance for Soft Tissue Reconstruction Product